Postmenopausal Symptoms Clinical Trial
Official title:
The Effects of PNF and Frenkel's Exercises on Balance, Fall Risk, and Quality of Life in Postmenopausal Women
NCT number | NCT04266067 |
Other study ID # | HYSS2019 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 1, 2018 |
Est. completion date | August 30, 2019 |
Verified date | February 2020 |
Source | Ege University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Postural stability is impaired due to the decrease in estrogen in the postmenopausal period,
which may lead to disruption of balance and risk of falling. Our objective was to investigate
the effects of PNF and Frenkel's exercises on balance, fall risk, and quality of life in
postmenopausal women.
Methods: Forty-eight postmenopausal women were randomized into PNF (n = 24) (5 days a week)
and Frenkel (n = 24) (5 days a week as a home exercise program) exercise groups. Hand grip
strength, quality of life (short form- 36), falling risk (Falls Risk of Older
People-Community Setting [FROP-COM]), and balance (functional reach test [FRT], one - leg
stand test [OLST], timed up and go test [TUG], and Berg balance scale [BBS]) of all patients
were evaluated prior to treatment, and at 4th week follow-up. The treatment responses were
evaluated at the beginning, and at the 4th week.
Status | Completed |
Enrollment | 48 |
Est. completion date | August 30, 2019 |
Est. primary completion date | August 30, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 50 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Postmenopausal women aged between 50-80 years who can walk independently were included in the study Exclusion Criteria: - 1. Having diabetic retinopathy and nephropathy, 2. The presence of plantar ulcers, 3. Presence of coronary artery disease, 4. Presence of peripheral vascular disease, 5. Presence of vision disorders, 6. Having a history of use of assistive walking device, 7. Presence of severe neurological, muscular or rheumatologic disease, 8. History of alcohol use, 9. Having lower limb amputation, 10. Presence of dementia, 11. Having a malignancy history, 12. Having a hearing problem, 13. Using a drug affecting balance, 14. Patients included in regular exercise program, and 15. Presence of neurological diseases affecting balance (stroke, multiple sclerosis, Parkinson's disease, epilepsy, etc.). |
Country | Name | City | State |
---|---|---|---|
Turkey | Hilal Yesil | Afyon | Eyalet/Yerleske |
Lead Sponsor | Collaborator |
---|---|
Hilal Yesil |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline Falls Risk for Older People-Community Setting (FROP-COM) score at 4 th week. | FROP-COM); includes 13 fall risk factor sections. The sum of the individual scores provides a total fall risk score ranging between 0 and 60 and higher scores refer to higher risks. While scores between 0-20 are evaluated as low- moderate fall risk, those between 21-60 scores are evaluated as high fall risk | up to 4 weeks | |
Secondary | change from baseline Functional reach test score at 4 th week | Functional reach test is a performance-based test measuring the maximum distance a person can reach while standing in a fixed position without losing balance, taking a step or touching a wall. The patients were asked to reach forward as far as possible without falling and stepping. The distance between the start and end positions was measured and recorded. Three trials were conducted and the average of the last two was noted . | up to 4 weeks | |
Secondary | change from baseline one leg stand test score at 4 th week | One leg stand test; as the starting position, the patients were asked to stand in a relaxed way with their eyes open with evenly distributed weight on both feet. The patients were then asked to stand freely on one leg for as long as possible. The test was terminated after 30 seconds or when the patient's foot touched to the ground. Then, the time was recorded | up to 4 weeks | |
Secondary | change from baseline timed up and go test score at 4 th week | Timed up and go test; the patient was asked to stand up while sitting in a chair, to walk to a line three meter away at a comfortable and safe speed and then return back and sit again on the chair. In this process, time was kept with stopwatch. In order to determine fall risk, a cut-off point of =13.5 seconds was used | up to 4 weeks | |
Secondary | change from baseline berg balance scale score at 4 th week | Berg balance scale (BBS) is a scale consisting of 14 items. Each of these items is scored between 0 and 4. "0" indicates that the task cannot be done. As the score goes to 4, the patient completes the task independently. Total score range is between 0 and 56. Here, while 0 point reflect the worst balance, 56 points refer to the best balance | up to 4 weeks | |
Secondary | change from baseline hand grip strength test score at 4 th week | Hand grip strength test; was evaluated with JAMAR dynamometer (BASELINE hydraulic hand dynamometer FEI White Plains, NY 10602 USA). The patients were asked to sit flat, hold their upper arm in a neutral position and keep their elbows at 90° flexion. The forearm was held in a neutral position and they were asked to hold their elbow in extension between 0 and 30°. The patient was then asked to grip the device with all of his/her strength. | up to 4 weeks | |
Secondary | change from baseline short form 36 score at 4 th week | Short form (SF)- 36; is a generic scale frequently used to assess quality of life. SF-36 is composed of 36 items used in the calculation of 8 different scale scores and consists of the following eight subscales. While 0 point indicates the worst health status, 100 points signify best health status. | up to 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06369363 -
Estrogen Deficiency on Cardiovascular Risk
|
Early Phase 1 | |
Not yet recruiting |
NCT01170195 -
Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00535288 -
Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)
|
Phase 3 | |
Recruiting |
NCT06030388 -
Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women
|
N/A | |
Not yet recruiting |
NCT05557799 -
Photobiomodulation in Post Menopause Genitourinary Syndrome
|
Phase 1/Phase 2 | |
Recruiting |
NCT04893226 -
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
|
N/A | |
Completed |
NCT03684096 -
Effect of Non-estrogenic Pollen Extract PCC-100 on Hot Flushes
|
N/A | |
Completed |
NCT01268046 -
Aging and Estrogen on Cortical Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05659693 -
The Effect of Digital Literacy Education Given to Postmenopausal Women on Health Literacy and Quality of Life
|
N/A | |
Completed |
NCT03572153 -
A Mind-Body Intervention for Hot Flash Management
|
N/A | |
Not yet recruiting |
NCT06419972 -
Multimodal Program for Climacteric Women
|
N/A | |
Not yet recruiting |
NCT06197568 -
Open-Label Study of Vaginal AZU-101 in Postmenopausal Women
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03854396 -
Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT01361308 -
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
|
Phase 3 | |
Unknown status |
NCT00905723 -
The Effects of Isoflavone and Estrogen in Sex Response in Climacteric Women
|
Phase 3 | |
Recruiting |
NCT05351476 -
Exercise Training and Fat Metabolism in Postmenopausal Women
|
N/A | |
Completed |
NCT06096818 -
Kegel and Abdominal Exercises on Urinary Incontinence Severity, Quality of Life, and Sleep Quality in Menopausal Women
|
N/A | |
Completed |
NCT03150407 -
Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness
|
N/A | |
Recruiting |
NCT06220266 -
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
|
Phase 2/Phase 3 | |
Recruiting |
NCT04129060 -
Cholinergic Health After Menopause (CHAMP)
|
Early Phase 1 |